APA (7th ed.) Citation

Boo, S. H., O, J. H., Kwon, S. J., Yoo, I. R., Kim, S. H., Park, G. S., . . . Cho, S. (2019). Predictive Value of Interim and End-of-Therapy 18F-FDG PET/CT in Patients with Follicular Lymphoma. Nuclear medicine and molecular imaging, 53(4), 263-269. https://doi.org/10.1007/s13139-019-00602-0

Chicago Style (17th ed.) Citation

Boo, Sun Ha, Joo Hyun O, Soo Jin Kwon, Ie Ryung Yoo, Sung Hoon Kim, Gyeong Sin Park, Byung Ock Choi, Seung Eun Jung, and Seok-Goo Cho. "Predictive Value of Interim and End-of-Therapy 18F-FDG PET/CT in Patients with Follicular Lymphoma." Nuclear Medicine and Molecular Imaging 53, no. 4 (2019): 263-269. https://doi.org/10.1007/s13139-019-00602-0.

MLA (9th ed.) Citation

Boo, Sun Ha, et al. "Predictive Value of Interim and End-of-Therapy 18F-FDG PET/CT in Patients with Follicular Lymphoma." Nuclear Medicine and Molecular Imaging, vol. 53, no. 4, 2019, pp. 263-269, https://doi.org/10.1007/s13139-019-00602-0.